DBI and hepatocellular carcinoma: In accord with the gene/protein expression data, HCC cells were particularly vulnerable to losing their viability in response to the combination of Dbi knockout and the addition of pharmacological ferroptosis inducers including RSL3, imidazole ketone erastin (IKE), linoleic acid, and linolenic acid (Figures 7A–7D).